1. Home
  2. MAGNECINE® Non-steroidal, Non-opioid, Analgesic Intravenous Spinal Pain Relief

MAGNECINE® Non-steroidal, Non-opioid, Analgesic Intravenous Spinal Pain Relief

A patented IV therapy that non-surgically relieves spinal disc pain using anti-inflammatory and antioxidant agents.

  1. General Details

    This patented composition and its method of use introduce the first non-steroidal, non-opiod analgesic for treatment-resistant pain due to Painful Damaged Disc Syndrome (PDDS).  This includes disc bulges, protrusions, and herniations.  The proprietary composition and its method are the first analgesic medications designed specifically for damaged, painful discs, and this treatment’s effectiveness is over 90%.

    The treatment combines a well-known anti-inflammatory agent, its derivatives and analogues, with a magnesium salt, recognized for its antioxidant, vasodilating, and antispasmodic properties.

    This patented method offers a promising solution for individuals suffering from chronic back pain and spine-related discomfort, setting a new standard in pain management. After a series of treatments, the pain most often does not return, and improved spinal health is achieved. This patented composition and its method of use will, in many cases, replace the need for invasive spinal epidural injections and surgeries.

    For licensing or collaboration opportunities, contact us today.

  2. Patent Portfolio

    The IP and assets available for sale include: 

    • US11951084 – Composition for the treatment of refractory painful intervertebral disc related disorders and method for delivery thereof to treat thereto
    • US20240358660 – Composition for the treatment of refractory painful intervertebral disc related disorders and method for delivery thereof to treat thereto
    • WO2024226223 – Composition for the treatment of refractory painful intervertebral disc related disorders and method for delivery thereof to treat thereto
    • Trademark Serial No. 97888177 – MAGNECINE
  3. Data Room Access & Additional Details

    Other Public Data Room Materials Available at VIP-3390 Public Data Room for MAGNECINE® Non-steroidal, Non-opioid, Analgesic Intravenous Spinal Pain Relief IP:

    • Introductory Materials
    • Patents, Patent Applications, and Trademark
    • Patent and Trademark File Histories
    • Patent Assignment and Ownership
    • Early Patient Results
    • Non-Disclosure Agreement Draft to access more files listed below

    Additional Materials (available upon signing a mutual non-disclosure agreement):

    • Due Diligence Review
    • Synergistic Mechanism
    • Investor Presentation
  4. More Information

    Pricing guidance for this transaction may be available. All parties interested in the IP above are authorized to contact Orlando Tsosie at Vibrant IP, LLC at orlando@vibrantip.com or at +1-801-641-8139.

Created with Visual Composer